Authors: Dongying Liu Guangru Xie Ming Chen
Publish Date: 2013/05/03
Volume: 19, Issue: 2, Pages: 280-287
Abstract
The median age of diagnosis of MBC was 62 years which was 9 years older than female breast cancer FBC patients The highest proportion of MBC patients was in the 50–59year age group The percentage of invasive ductal carcinoma in MBC was much higher than in FBC P = 0000 The positive rate of estrogen receptors in MBC patients 879 was significantly higher than in FBC patients P = 0048 whereas HER2 was positive in 172 of MBC patients which was significantly lower than in FBC patients P = 0001 There was a consistent significant difference in luminal subtypes of FBC and MBC patients P = 0000 The overall survival rates of MBC were significantly higher than FBC P = 0004 HER2positive patients had a statistically worse prognosis than HER2negative patients P = 0040 Lymph node metastasis and larger tumor size were also associated with poorer prognosis P = 0056 and P = 0088 The level of hormones was examined in 7 patients and abnormal hormone levels were detected in 4
Keywords: